Home » Stocks » DVA

DaVita Inc. (DVA)

Stock Price: $102.19 USD -0.70 (-0.68%)
Updated Feb 25, 2021 3:59 PM EST - Market closed
After-hours: $102.14 -0.05 (-0.05%) Feb 25, 4:02 PM
Market Cap 11.20B
Revenue (ttm) 11.55B
Net Income (ttm) 773.64M
Shares Out 119.80M
EPS (ttm) 6.31
PE Ratio 16.19
Forward PE 12.50
Dividend n/a
Dividend Yield n/a
Trading Day February 25
Last Price $102.19
Previous Close $102.89
Change ($) -0.70
Change (%) -0.68%
Day's Open 103.17
Day's Range 101.23 - 103.87
Day's Volume 537,425
52-Week Range 62.20 - 125.28

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation
GuruFocus - 1 day ago

Francis Chou (Trades, Portfolio), manager of Chou Associates Management, disclosed last week that his firm's top four sells during the fourth quarter of 2020 included the closure of its positi...

Other stocks mentioned: ALGT, GS, SAVE
Zacks Investment Research - 3 days ago

Investors' confidence is high on the DaVita (DVA) stock, thanks to solid prospects.

Zacks Investment Research - 1 week ago

DaVita's (DVA) bottomline in Q4 declines year over year.

Zacks Investment Research - 1 week ago

DaVita HealthCare (DVA) delivered earnings and revenue surprises of -9.73% and -1.00%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the s...

Benzinga - 1 week ago

Shares of DaVita (NYSE:DVA) decreased after-market trading after the company reported Q4 results. Quarterly Results Earnings per share fell 10.22% year over year to $1.67, which missed the est...

PRNewsWire - 2 weeks ago

BOSTON, Feb. 6, 2021 /PRNewswire/ -- Kyros Law Offices is alerting investors of Davita Inc (NYSE:DVA) that the deadline in filing claims from the investor lawsuit settlement against the compan...

Zacks Investment Research - 2 weeks ago

Solid performance by net dialysis and the related lab patient service segment is likely to have contributed to DaVita's (DVA) top line in the fourth quarter.

PRNewsWire - 3 weeks ago

DENVER, Jan. 29, 2021 /PRNewswire/ -- DaVita Inc. (NYSE: DVA), announced today that it will hold its quarterly conference call to discuss fourth quarter results on Thursday, February 11, 2021,...

Zacks Investment Research - 1 month ago

3 Outpatient Home Health Stocks Set to Ride the Industry's Upturn

Other stocks mentioned: CHE, USPH
Benzinga - 1 month ago

DaVita Inc. (NYSE: DVA) is focused on dialysis, which means that it is unlikely to get much of a boost from a reacceleration in volumes within health care, of which Tenet Healthcare Corp (NYSE...

Zacks Investment Research - 1 month ago

Investor confidence is high on DaVita (DVA) stock, driven by its solid prospects.

Zacks Investment Research - 1 month ago

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to th...

Zacks Investment Research - 1 month ago

DVA vs. CHE: Which Stock Is the Better Value Option?

Other stocks mentioned: CHE
PRNewsWire - 2 months ago

DENVER, Dec. 22, 2020 /PRNewswire/ -- Today, DaVita Kidney Care announced that more than 100,000 DaVita patients have received a kidney transplant since 2000. This milestone represents the cul...

Zacks Investment Research - 2 months ago

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to th...

InvestorPlace - 2 months ago

Some reasonably cheap stocks are growth stocks in disguise. If you're looking for undervalued stocks, these 10 are about to take off.

Other stocks mentioned: CWH, DG, GM, GOLD, HMC, INTC, NOAH, TPX, WWE
InvestorPlace - 2 months ago

As uncertainty continues and growth stocks remain richly priced, these 10 value stocks could be your ticket to gains in 2021. The post The 10 Most Reliable Value Stocks to Buy for 2021 appeare...

Other stocks mentioned: CAH, GHC, HPQ, KR, MMM, MO, PPL, SNA, T
Zacks Investment Research - 2 months ago

DVA vs. CHE: Which Stock Is the Better Value Option?

Other stocks mentioned: CHE
Forbes - 2 months ago

Markets rose on Thursday after jobless claims from last week came in at much better than expected figures. For investors looking to make the most of this market, our deep learning algorithms h...

Other stocks mentioned: KW, MO, PRI, TGNA
Zacks Investment Research - 2 months ago

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to th...

Zacks Investment Research - 2 months ago

Is DaVita (DVA) a great pick from the value investor's perspective right now? Read on to know more.

Zacks Investment Research - 2 months ago

If you are looking for a fast-growing stock that is still seeing plenty of opportunities on the horizon, make sure to consider DaVita (DVA).

Zacks Investment Research - 3 months ago

As of late, it has definitely been a great time to be an investor in DaVita (DVA).

Zacks Investment Research - 3 months ago

DVA vs. CHE: Which Stock Is the Better Value Option?

Other stocks mentioned: CHE
PRNewsWire - 3 months ago

DENVER, Nov. 23, 2020 /PRNewswire/ -- DaVita Inc. today announced its annual cycling event, Tour DaVita, raised nearly $1 million to benefit Bridge of Life, a nonprofit founded by DaVita that ...

Zacks Investment Research - 3 months ago

Investor confidence is high on DaVita (DVA) stock, thanks to solid prospects.

Zacks Investment Research - 3 months ago

Is (DVA) Outperforming Other Medical Stocks This Year?

Zacks Investment Research - 3 months ago

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to th...

Insider Monkey - 3 months ago

Many prominent investors, including Warren Buffett, David Tepper and Stan Druckenmiller, have been cautious regarding the current bull market and missed out as the stock market reached another...

Zacks Investment Research - 3 months ago

DVA vs. CHE: Which Stock Is the Better Value Option?

Other stocks mentioned: CHE
PRNewsWire - 3 months ago

SACRAMENTO, Calif., Nov. 4, 2020 /PRNewswire/ -- DaVita Kidney Care, a leading provider of kidney care services in the United States, issued the following statement: "We are grateful that Cali...

Investors Business Daily - 3 months ago

Davita Healthcare Partners sees its Relative Strength Rating move into the 80-plus level. The post Davita Healthcare Partners Clears Key Benchmark, Hitting 80-Plus RS Rating appeared first on ...

Zacks Investment Research - 3 months ago

Investors target stocks that have been on a bullish run, lately. Stocks seeing price strength have higher chances of carrying the momentum ahead.

Other stocks mentioned: EAT, GPI, HMST, MMSI, OMI
Zacks Investment Research - 3 months ago

Rise in coronavirus cases and uncertainties revolving around the election might keep markets volatile for some time. Here are five stocks to invest in and play safe.

Other stocks mentioned: OMI, PRMW, SAM, UNFI
Zacks Investment Research - 3 months ago

DaVita (DVA) saw strength in dialysis services in the United States in the third quarter.

Seeking Alpha - 3 months ago

DaVita, Inc. (DVA) CEO Javier Rodriguez on Q3 2020 Results - Earnings Call Transcript

Zacks Investment Research - 3 months ago

DaVita HealthCare (DVA) delivered earnings and revenue surprises of 20.81% and -0.60%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the ...

PRNewsWire - 3 months ago

DENVER, Oct. 29, 2020 /PRNewswire/ -- DaVita Inc. (NYSE: DVA) announced financial and operating results for the third quarter ended September 30, 2020. During the quarter, notwithstanding the ...

Zacks Investment Research - 3 months ago

Coronavirus is going to affect the earnings results of healthcare players. While hospitals and health insurers might have suffered the COVID-19 impact, others providing virtual care and COVID-...

Other stocks mentioned: CHE, CRL, NVCR, UHS
Zacks Investment Research - 3 months ago

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to th...

Zacks Investment Research - 3 months ago

Solid performance by the net dialysis and related lab patient service segment is likely to have contributed to DaVita's (DVA) top line in the third quarter.

Zacks Investment Research - 4 months ago

DaVita HealthCare (DVA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Investment Research - 4 months ago

Is (DVA) Outperforming Other Medical Stocks This Year?

PRNewsWire - 4 months ago

DENVER, Oct. 22, 2020 /PRNewswire/ -- DaVita Clinical Research (DCR) will present 14 research abstracts from company representatives and medical professionals at the American Society of Nephro...

The Motley Fool - 4 months ago

Many Warren Buffett stocks remain buys.

Other stocks mentioned: GOLD, STNE
PRNewsWire - 4 months ago

DENVER, Oct. 15, 2020 /PRNewswire/ -- DaVita Inc. (NYSE: DVA), announced today that it will hold its quarterly conference call to discuss third quarter results on Thursday, October 29, 2020, a...

Zacks Investment Research - 4 months ago

DaVita HealthCare (DVA) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Zacks Investment Research - 4 months ago

Grab these four stocks that continue to show tremendous promise despite market volatility resulting from the coronavirus pandemic.

Other stocks mentioned: LHCG, OMI, RMD
Seeking Alpha - 4 months ago

DaVita's business model is able to provide the company with very reliable and stable revenues, as patients need their dialysis treatment on a constant basis.

Zacks Investment Research - 4 months ago

These three MedTech stocks are expected to grow post their Q3 earnings release.

Other stocks mentioned: ARAY, CAH

About DVA

DaVita provides kidney dialysis services for patients suffering from chronic kidney failure or end stage renal disease (ESRD). The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also provides outpatient, hospital inpatient, and home-based hemodialysis services; owns clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In ad... [Read more...]

Industry
Medical Care Facilities
IPO Date
Oct 31, 1995
CEO
Javier Rodriguez
Employees
67,000
Stock Exchange
NYSE
Ticker Symbol
DVA
Full Company Profile

Financial Performance

In 2020, DaVita's revenue was $11.55 billion, an increase of 1.42% compared to the previous year's $11.39 billion. Earnings were $773.64 million, a decrease of -4.60%.

Financial Statements

Analyst Forecasts

According to 12 analysts, the average rating for DaVita stock is "Hold." The 12-month stock price forecast is 120.75, which is an increase of 18.16% from the latest price.

Price Target
$120.75
(18.16% upside)
Analyst Consensus: Hold